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Abstract
Blastomere fate and embryonic genome activation (EGA) during human embryonic development are unsolved areas of high
scientific and clinical interest. Forty-nine blastomeres from 5- to 8-cell human embryos have been investigated following an
efficient single-cell cDNA amplification protocol to provide a template for high-density microarray analysis. The previously
described markers, characteristic of Inner Cell Mass (ICM) (n = 120), stemness (n = 190) and Trophectoderm (TE) (n = 45), were
analyzed, and a housekeeping pattern of 46 genes was established. All the human blastomeres from the 5- to 8-cell stage
embryo displayed a common gene expression pattern corresponding to ICM markers (e.g., DDX3, FOXD3, LEFTY1, MYC,
NANOG, POU5F1), stemness (e.g., POU5F1, DNMT3B, GABRB3, SOX2, ZFP42, TERT), and TE markers (e.g., GATA6, EOMES, CDX2,
LHCGR). The EGA profile was also investigated between the 5-6- and 8-cell stage embryos, and compared to the blastocyst
stage. Known genes (n = 92) such as depleted maternal transcripts (e.g., CCNA1, CCNB1, DPPA2) and embryo-specific
activation (e.g., POU5F1, CDH1, DPPA4), as well as novel genes, were confirmed. In summary, the global single-cell cDNA
amplification microarray analysis of the 5- to 8-cell stage human embryos reveals that blastomere fate is not committed to
ICM or TE. Finally, new EGA features in human embryogenesis are presented.
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Introduction
Embryonic developmental fate can be described as a progressive
loss of totipotency, whose primary outcome is commitment and
differentiation into inner cell mass (ICM) and trophoectoderm
(TE) [1,2]. During this period maternal transcripts/proteins
control the developmental program until embryonic genome
activation (EGA) occurs [3].
Embryo developmental fate in mammals has been investigated
mostly in the mouse model, and two distinct hypotheses have been
put forward. The first proposes that polarity predetermination
takes place before the 2-cell stage where cells adopt differential
positions, either inside or outside, depending on the orientation of
the cell divisions along the animal-vegetal (AV) axis; thus
blastomere fate could be predisposed from fertilization [4–11].
The second model stresses that the mouse embryo is entirely
symmetric, and that it neither, has an AV nor shows any other
pre-patterning. According to this view, 2-cell blastomeres do not
differ and their precise contribution to ICM and/or TE cannot be
anticipated at this early stage, but later in the morula stage when
inner cells contribute to ICM, whereas outside cells differentiate
into TE [12–17]. In this context, previous studies in the human
embryo have also indicated this duality where either the single
blastomeres depending on the cleavage planes would determine
later developmental fate [18] or the blastomere would exhibit
totipotent behaviour during early human development [2].
The genetic mechanisms governing EGA have been well
documented in Caenhorabditis elegans, Drosophila melanogaster and
Xaenopus laevis [19–21]. EGA starts at the 4 to 8-cell stage in
human embryos [3,22,23] and occurs in a stepwise manner where
maternal mRNAs must be depleted, while the transcripts required
for growth and differentiation are expressed for the first time, as
has been well established in mice [24–29]. However, information
about this genetic transfer in human embryos is lacking.
Global genome assays provide vast amounts of gene expression
profile information and could help to clarify these unsolved scientific
issues. Single-cell cDNA microarrays analysis of single blastomeres
has been successfully performed in mice [30,31], but not in humans.
Previous studies have revealed not only the ICM gene signature in
mouse and human embryos [31,32], but also stemness [2,33–35],
and TE that [36] gene signatures could be used to determine
putative differentiation in blastomeres in early preimplantation
embryos. Our results indicate that all the blastomeres analyzed in the
5-6- and 8-cell stage embryos show a common transcript pattern,
suggesting that cell fate commitment to ICM or TE is still to be
determined at these embryonic stages. Furthermore, the embryo
genome activation (EGA) process is confirmed at the single
blastomere level in the 5-8-cell stage human embryos.
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Results
Global Gene Expression Profile of Single Human
Blastomeres
A total of fifty-five blastomeres corresponding to 5-cell (n = 4)
(11 blastomeres), 6-cell (n = 4) (20 blastomeres), 8-cell embryos
(n = 3) (24 blastomeres), and to two blastocysts (n = 2) (2 inner cell
masses (ICM) and 2 trophectoderms (TE)) were processed and
cDNA amplified as shown in Figure 1. The signal quality in the
microarrays hybridized to biological samples was compared to that
of the negative control (in water subjected to the same
amplification and hybridization protocol). Those arrays whose
signal distribution did not significantly differ from the control one
according to Wilcoxon’s test, were discarded (n = 6). Finally, 53
samples were kept in the study and used in the gene expression
analysis, including 8 blastomeres from 5-cell, 19 from 6-cell, 22
from 8-cell, 2 ICM and 2 TE from blastocyst stage embryos
(Figure 1). For convenience, we use the term ‘‘gene’’ instead of
‘‘gene feature’’ in the microarray data descriptions.
A total of 26,504 data points were assigned from known and
novel genes, including transcripts that are specific to ICM,
stemness and TE. Unsupervised hierarchical clustering mainly
distinguished two groups, one consisting in blastocysts and the
other from single blastomeres (not shown). Differential gene
expression analysis was performed comparing 5-, 6-, and 8-cell
embryos between them as well as with ICM and TE samples.
Figure 1. Experimental design. (A) Blastomere biopsy and ICM and TE isolation procedures. (B) Schematic representation of the experimental
design. A total of 55 biopsied single blastomeres, 2 ICM and 2 TE were cDNA amplified and in vitro transcribed for microarray analysis. The signal
quality in the microarrays hybridized to biological samples was compared to that of the negative control, and 6 samples were finally discarded. The
normalized data from the 5-, 6- and 8-cell embryos single blastomeres microarrays were compared to each other and with ICM and TE to check for
the gene expression related with ICM, stemness, TE and the EGA signature.
doi:10.1371/journal.pone.0013615.g001
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Limma t-statistic methodology, followed by a Benjamini &
Hochberg p-value correction was computed using Babelomics
web tool (see Methods). A significance level of 0.05 in the
corrected p-values was used to call genes differentially expressed.
Numerous significant differences were found when comparing 5-,
6-, and 8-cell embryos with the ICM- and TE-isolated and
amplified samples but fewer when comparing the 5- to 8-embryos
among them as revealed by the gene set analysis (Table 1; Table
S1).
The same pattern of strong differences between blastomeres and
ICM and TE samples and of weak differences among blastomeres
was found in the Gene Set Analysis for the Gene Ontology terms
and the KEGG pathways using the Babelomics functional
profiling tools (see Methods). No KEGG pathways and very few
GO terms were enriched when comparing 5-, 6-, and 8-cell
embryo blastomeres among them. Of those, the most relevant
functions involved RNA and DNA processing and were enriched
in 5-cell compared to 6-, and 8-cell embryo blastomeres. This
might be indicative of the maternal mRNA degradation and the
beginning of embryonic gene activity. When comparing 5-, 6-, and
8-cell embryos with ICM and TE, most diverse biological
functions were found significantly enriched, indicating strong
functional differences between these two embryonic developmen-
tal stages.
Global gene expression values were also employed to investigate
whether a single blastomere could have a differential transcrip-
tome in the 5- to 8- cell embryos. For that purpose, the correlation
among all the blastomeres from the same complete embryo (intra-
embryo) or from different embryos (inter-embryo) was compared.
Mann Whitney, Students t- and Kolmogorow-Smirnov tests all
agreed in that general intra-embryo correlation (.0.8) was
significantly higher than inter-embryo (.0.7) correlation. This
suggests that differences among the transcriptomes from blasto-
meres in the same complete embryo are much less than differences
between embryos, and herein no potential blastomere commit-
ment at the 5- to 8- cell stage can be inferred.
Blastomeres from 5 to 8-cell stage embryos show a
common ICM, stemness and trophectoderm gene
signature
Housekeeping profile pattern. Housekeeping genes should
be generally highly expressed and stable, meaning not variable,
across samples. To search for genes accomplishing the first
condition, we kept only those that had a gene expression
measurement above the 3rd quartile of the intensity distribution
in all arrays. To find those that, in addition were stable, we kept
the genes having low standard deviation as well as low
interquartile range (sd, iqr ,1). (Figure 2A). Forty-six genes
corresponding to the structural constituent of ribosome (RPL10L,
RPLP1, RPS13, RPS24, RPL10A, RPS17, A_24_P375435,
ENST00000359659), the cell surface (A_24_P551530, BCAM),
ion channels (CYB561D1, HCN2, TPT1), the endopeptidase
activity (TPSG1, CASP8), related to inflammatory response
(LY86), autophagy (MAP1LC3A), DNA topological change
(EXOC3L2) and chromatin (HIST3H3), cyclin-dependent protein
kinase activity (A_32_P101195), and regulation of cell growth
(OGFR), were identified (Figure 2A). The inclusion of traditional
reference genes such as HPRT1, GAPDH and ACTB [37,38,39]
was discarded. Furthermore, 13 human novel genes recently
described as universal markers, including ARL18B, CTBP1, or
ZNF207 [38] were not included in the selected list. Finally, one
gene belonging to the group of genes related with ribosomal
proteins, RPS24, was selected as the housekeeping gene for the
validation assays in this study.
ICM gene profile. One hundred and twenty genes
previously reported to be characteristic of human ICM
[1,2,32,40] and mouse ICM [24,31] signatures were analyzed in
the single blastomeres from the 5- to 8- cell stage embryos (Table
S2). A cross-species analysis for human homologs was done. ICM
markers including DDX3, DNMT3L, FOXD3, JAK2, LEFTY1,
MYC, NANOG, POU5F1, RPL19, SOX2, XIST or ZFP42 displayed
no significant differences between either the blastomeres belonging
to the same stage embryo or the different cell stages, except
Table 1. General gene set analysis.
1 0 21
KEGG E8.E5 0 43 0
E6.E5 0 43 0
E8.E6 0 43 0
ICM.E8 20 14 9
ICM.E6 17 17 9
ICM.E5 13 27 3
TE.E8 19 13 11
TE.E6 23 7 13
TE.E5 16 20 7
Biological Process E8.E5 0 255 11
E6.E5 1 238 27
E8.E6 0 266 0
ICM.E8 155 78 33
ICM.E6 166 66 34
ICM.E5 113 134 19
TE.E8 142 86 38
TE.E6 143 85 38
TE.E5 103 140 23
Molecular Function E8.E5 0 186 3
E6.E5 7 172 10
E8.E6 0 189 0
ICM.E8 96 46 47
ICM.E6 93 52 44
ICM.E5 58 111 20
TE.E8 98 50 41
TE.E6 101 47 41
TE.E5 59 114 16
Cellular Component E8.E5 1 101 16
E6.E5 2 89 27
E8.E6 0 118 0
ICM.E8 73 28 17
ICM.E6 71 29 18
ICM.E5 50 57 11
TE.E8 71 28 19
TE.E6 72 28 18
TE.E5 44 66 8
Number of significant KEGG, biological process, molecular function and cellular
component terms in each comparison. 1 means over-representation of the term
in the first class, 0 means no significant terms, and -1 means over-
representation of the term in the second class. Significant terms appear neither
in the KEGG analysis nor in any 6-8-cell stage embryos comparison. The
complete gene set analysis can be found in Supplemental Table S1.
doi:10.1371/journal.pone.0013615.t001
Human Blastomere Transcriptome
PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13615
TGFBR1 which was overexpressed in the 5-cell stage embryos
compared to the 6- and 8-cell stage embryos (Figure 2B1). As
expected, when the single blastomeres from the 5-, 6- and 8- cell
stage embryos were compared to ICM, significant differences were
found in 34 genes (Figure 2B2). Twenty-eight genes were
overexpressed in ICM, including DNMT3L, POU5F1, SMAD4 or
Figure 2. Gene expression analysis and blastomere fate. (A) List of the putative housekeeping genes common for blastomeres, and the ICM
and TE cells from the blastocysts. Those genes with higher values and a low standard deviation (sd iqr ,1) (values corresponding to quantile 25 with
a sd iqr less than 1) were chosen as putative housekeeping genes (X axis). The maximum data score value in the microarray is 17.5 and 1.63 the
minimum (Y axis). (B) Comparative analysis of ICM, stemness and TE gene markers in the single blastomeres from the 5-, 6- and 8- cell embryos (1)
were compared to the ICM and TE differentiated cells (2). (1) No statistical difference (p value,0.05) was found for most markers except for RRAS2,
FZD5 and TGFBR1 (underlined and in bold), which were up-regulated in 5-cell embryo blastomeres compared to the 6-cell (RRAS2), 8-cell (FZD5), and
to both of them (TGFBR1). (2) Heat map representation of the significant differential expression (p value,0.05) between the 5- and 8- single
blastomeres with ICM and TE. Gray indicates no significant differences. Red means an overexpression in the ICM or TE samples, and blue depicts an
over-representation in the single blastomere samples. The color code of the expression level is indicated at the top of the figure. The complete data
can be checked in Supplementary Table S2.
doi:10.1371/journal.pone.0013615.g002
Human Blastomere Transcriptome
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XIST, and 6 were overexpressed in blastomeres, namely TGFBR1,
FOXD3, SBNO1, ZFAND5, CCNB1, and MYC.
Stemness gene profile. The stemness gene signatures
composed of 190 genes [1,2,25,32–35,41–48] were used to
compare the blastomeres from the 5-, 6- and 8- cell stage
embryos (Table S2). All the genes were present in the array, and
no significant differences were found between either the
blastomeres from the same stage or different stages, except
RRAS2 and FZD5 which were overrepresented in the 5-cell
embryo blastomeres compared to those from the 6- and 8- cell
embryos respectively (Figure 2B1). Characteristic stemness genes
including NANOG, DNMT3B, GABRB3, GDF3, SOX2, POU5F1,
ZFP42, and TERT were all detected in every blastomere analyzed
irrespectively of the developmental stage. Furthermore, a group of
markers were selected as they were quite stably and highly
expressed in all 49 blastomeres, namely DPPA5, FOXD3, HDAC2,
RPL19, RPL4, TERT, THY1 and UTF (Table S2). Therefore, these
could be used as a molecular set to identify the blastomeres from
the 5- to 8-stage developmental embryos. When the blastomeres
from the three developmental stages were compared to ICM
amplified samples, 26 were found to be significantly overexpressed
in ICM versus blastomeres such as GDF3, KRT18, and TDGF1,
among others, and 3 were highly expressed in blastomeres,
including TERT, FRAT2, and DPPA5. The common studied genes
for both ICM and stemness were IFITM2, XIST, HMGB1,
POU5F1, PUM1, SMAD4, SMAD5, EPRS, and FOXD3. It is
interesting to note that KRT18 has been described for both
stemness and TE signatures (Figure 2B2).
Trophectoderm gene profile. To check for primary
differentiation to the TE, 45 genes which have been previously
reported to be involved in its differentiation were investigated in all
the single blastomeres from the 5- to 8-cell stage embryos
[1,2,18,25,33,36,40,45,49–51] (Table S2). The cross-species
homologs from mice were selected whenever necessary. No
significant differences were observed among all the blastomeres
from the same and different (5-, 6- or 8-cell) stage embryos, and all
the markers, including GATA6, EOMES, CDX2, CDH24 or
LHCGR, displayed a score in the microarrays (Figure 2B1)
(Table S2). When the data values from single blastomeres were
compared to those obtained from the isolated TE from blastocysts,
8 gene markers were found to be highly expressed in the TE
samples including CDH1, CDX1, and KRT18, among others
(Figure 2B2).
By taking these considerations together, the gene expression
signature of ICM, stemness and trophectoderm showed no strong
differences between blastomeres from the 5- to 8- cell stage
embryos, while clear differences with differentiated ICM and TE
were displayed, thus suggesting no fate commitment at this early
developmental embryonic stage.
Transcriptomics of the embryonic genome activation
(EGA)
Embryonic genome activation (EGA) is a two-fold process that
requires maternal mRNA degradation and embryonic gene
activation between the 4- to 8-cell embryos in humans. In our
study, a comparative gene expression profile between the 5- to 8-
cell embryos at the single blastomere level revealed a novel
signature of EGA genes including 147 genes related with maternal
transcriptional depletion, and 6 genes involved in embryo genome
activation (Figure 3AB; Table S3). This is in agreement with
previous studies which demonstrate that maternal gene down-
regulation far outweighs embryonic gene up-regulation [22].
Based on their expression profiles, genes were joined in clusters
(Figure 3A). Those genes which underwent maternal degradation
in the 6-cell stage embryo (e.g., AMIGO1, ANXA3, TGFBR1) were
considered to be Cluster 1, while Cluster 2 included the
significantly down-regulated genes at the 8-cell stage (e.g.,
DMRTC2, FZD5, SMURF1). Gene activation involved CCT3
(Cluster 3) starting at the 6-cell stage embryos, and Cluster 4
including the genes activating at the 8-cell stage (ARL4D, SEC16B,
ZNF587). It is interesting to note that three other groups displayed
an intermediate pattern with those genes showing maternal
degradation, gene activation with a subsequent partial down-
regulation and gene expression depletion with final activation
(Figure 3B; Figure S1).
Furthermore, 92 human and mouse genes, which have been
previously described to take part in EGA, were chosen to be
compared in blastocysts versus the single blastomeres from the 5-
to 8-cell embryos (Table S3). Definitive maternal transcript
degradation was represented by 17 genes including DPPA5,
MYC or CLOCK, among others (Figure 3C), and the final
embryonic genome activation was confirmed by the overexpres-
sion of 17 genes including EIF1AX, POU5F1 or TEAD4 among
others (Figure 3C), which have already been described in other
animal species [11,22–27,52–60].
Microarray data validation
Gene expression validation was performed by quantitative PCR
(qPCR) using the amplified cDNA from the microarray surplus
and novel samples, as well as the non amplified cDNA from single
blastomeres, ICM and TE. Specifically, qPCR assays were
performed for a total of 13 genes including ICM markers
(POU5F1, DPPA5, MYC, HMGB1, IFITM2), stemness (POU5F1,
DPPA5, KRT18, IFITM2, HMGB1, RPL19), TE (KRT18, CDH1,
HAND1, CDX1), EGA (DPPA5, POU5F1, CCT3, MYC, CDH1) and
the putative housekeeping markers common to blastomeres, ICM
and TE (RPS24, RPL10L, RPL19). RPS24 was used as the
housekeeping reference gene in all cases. Most of the amplified
blastomere cDNA from the 5-, 6- and 8- cell embryos (n = 11, 20,
and 24, respectively), the 2 ICM and 2 TE used in the microarray
were used for the qPCR experiments. Furthermore, 2 more
biopsied ICM and TE from blastocysts were also amplified. Non
amplified samples also included 5-cell (n = 4, 4 blastomeres), 6-cell
(n = 2, 11 blastomeres), and 8-cell (n = 4, 30 blastomeres) embryos,
as well as the blastocysts (n = 5) biopsied for ICM and TE isolation.
In summary, the expression profile analysis of the genes
investigated confirmed microarray results (Figure 4).
Discussion
Understanding human preimplantation development from a
global genome perspective is crucial for basic embryology
research, regenerative medicine because of the derivation of
human embryonic stem cells (hESC) from single blastomeres
[61,62], and for translational applications in reproductive
medicine such as preimplantation genetic diagnosis (PGD)
[1,63,64].
To investigate cell fate in blastomeres from the 5- to 8-cell stage
embryos, we first looked at the global gene profile in all the
blastomeres from the same embryo, which resulted in a higher
intra-embryo correlation as compared to the inter-embryo
association. Next, we searched for a differential gene signature
among the blastomeres from the 5-, 6- and 8-cell stages according
to the previously described gene patterns of ICM and TE
[1,31,32,36,40], and stemness [62,65,66]. Markers of stemness are
responsible for controlling undifferentiation and immortality in
hESCs, thus they could be candidate genes for making
developmental decisions in early human embryos [2,34]. One
Human Blastomere Transcriptome
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Figure 3. Genes involved in embryonic genome activation (EGA). EGA entails maternal degradation from the genes existing in the
blastomeres (shown in blue) and the gene activation of the transcription factors of the embryo genome (shown in red). (A) The novel gene markers
involved in putative maternal degradation or genome activation in the 5- to 8- cell embryo blastomeres have been grouped into clusters according
to their gene expression profile. (B) List of markers showing an intermediate pattern in the 5- to 8- cell embryo blastomeres, including maternal
degradation at the 6-cell and slight activation later, gene activation at the 6-cell stage and slight subsequent down-regulation and a significant
overexpression in the 8-cell stage versus the 6-cell-stage blastomeres. (C) Definitive analysis of EGA involving the 5- to 8- cell embryos compared to
blastocysts. Gene expression profiles confirm previously reported results. Only those genes with statistically significant differences (p value,0.05)
have been considered for the analysis. The complete data can be checked in Supplemental Table S3 and Supplemental Figure S1.
doi:10.1371/journal.pone.0013615.g003
Human Blastomere Transcriptome
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hundred and twenty ICM genes, 190 stemness and 45 TE markers
were used to provide a wide spectrum to characterize the
blastomeres at the single cell level. All the blastomeres from the
5-, 6- and 8-cell embryos displayed expression levels for ICM,
stemness and TE markers, and no statistical differences were found
among them, except for TGFBR1, FZD5 and RRAS2 significantly
overexpressed in the 5-cell embryo blastomeres. Thus, gene
expression appeared to be similar in the single blastomeres
analyzed independently of both embryo-cell stage and origin.
Furthermore, a set of stably and highly expressed genes was
established to create a blastomere signature composed of the
DPPA5, FOXD3, HDAC2, RPL19, RPL4, TERT, THY1 and UTF
genes.
Additionally, single blastomere gene profiles were analyzed with
those obtained from isolated ICM and TE. First, a common
housekeeping gene expression for the three sample types was
established. This signature included a set of 46 genes involved in
ribosomal, cell surface and enzyme proteins, among others, and
conferred a unique reference pattern to human embryos (e.g.,
RPS24, RPL10L or RPL13). Previously characterized housekeeping
genes like GAPDH and ACTB, or the novel universal reference
genes (e.g., ARL18B or ZNF207) [39] were not included in our
Figure 4. Gene expression validation of the microarray data by qPCR. (A) Gene expression analysis was analysed in non amplified and
amplified samples in 5-, 6- and 8-cell embryo blastomeres with CCT3 primers, blastomeres and ICM (HMGB1, IFITM2), blastomeres and TE (CDX1,
HAND1), blastomeres, ICM and TE (KRT18), blastomeres, ICM and blastocysts (DPPA5, MYC, POU5F1), and blastomeres, TE and blastocysts (CDH1).
RPS24 was used as the reference gene in all cases. Results were compared with microarray data to check ICM, stemness, TE and EGA signatures. (B) Cp
values of the selected housekeeping genes in non amplified and amplified blastomeres, ICM and TE samples and their microarray counterparts. (C)
Gene list description for each category validation. Color legends used in the graphics is specified at the top right of the Figure.
doi:10.1371/journal.pone.0013615.g004
Human Blastomere Transcriptome
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housekeeping human embryo signature. When performing a
comparative analysis of the gene signatures between the isolated
blastomeres, ICM and TE, significant differences were found for
the characteristic markers POU5F1 or DNMT3B, which were
highly expressed in ICM, or DPPA5 and FOXD3 which were up-
regulated in the blastomeres, indicating a unique gene expression
pattern for blastomeres and blastocysts. According to this
differential pattern, hESCs derived from different sources may
have specific properties. The immortality gene marker TERT
(Telomerase) and the stemness keeper MYC were over-represented
in the single blastomeres if compared to ICM. Since TERT is
involved in the gradual decrease in the potential for unlimited
proliferation, and as MYC has an activating effect on telomerase
[67,68], the hESCs derived from the 5- to 8-cell stage blastomeres
are expected to have increased potential for propagation in vitro.
On the other hand, the highly expressed genes in ICM involved
characteristic stemness transcription factors such as POU5F1,
PUM1, GDF3, ETV4, FZD5, ZNF165 or TGF1, interferon-induced
transmembrane proteins IFITM1 and IFITM2, as well as members
of the intermediate filament gene family KRT8 and KRT18, which
are also characteristic of TE differentiation. Of special interest are
those genes involved in methylation, a crucial epigenetic
modification for embryonic development, imprinting and X-
chromosome inactivation. De novo methylation was observed in
the blastocyst to be restricted to ICM [69]. The differential
analysis in our study has revealed that de novo methylases
DNMT3A/B/L not only show a higher expression in ICM if
compared to blastomeres, but also their transcriptional regulated
gene H19 and the X inactivation XIST gene, thus confirming the
expected putative transcriptome and suggesting potential differ-
ences in hESCs in accordance with their origin.
In parallel, one of the most important embryo developmental
outcomes at the 5- to 8-cell stage is embryonic genome activation
(EGA) [22]. EGA failure leads to embryo arrest and eventual
implantation failure. Three main requirements need to be met for
successful genome activation, namely maternal mRNA degrada-
tion, embryonic gene transcription activation and epigenetic
changes. The differential expression profile between the 5- 6-
and 8-cell embryos demonstrates a putative novel EGA gene
signature, and shows a vast number of transcripts which are down-
regulated at the 6- and 8-cell levels if compared to the 5-cell stage
embryo (n = 147), plus a low number of up-regulated genes during
this period (n = 6). Maternal down-regulated genes include those
relating with the Wnt cannonical pathway (FZDZ5, also related
with stemness, TLE2, FRAT1) and the FGF/TGFB signaling
pathways (TGFBR1, FGFRL1, SMURF1), cell proliferation and
development (HOXB8, RRAS2, also related with stemness,
DUSP22), methylation (MBD3L2), apoptosis (PAK1, DUSP22), the
G-protein family (GABBR2, FZD5, LPAR2), cytoskeleton structure
(AFAP1L2, KRT6B, TLN2, RRAS2, also related with stemness,
HOMER2, and PAK1), immune response (ANXA3, AFAP1L2) and
histones (HIST1H14J) among others. The sex determination genes
DMRT1 and DMRT2 were also found to be depleted. No activated
gene presented a common ontological pattern except OR5P2 and
GNA14 which belong to the G-protein family.
Further assays comparing the 5-8-cell embryo blastomeres to the
blastocysts for the previously described genes involved in EGA
confirmed this developmental process. The maternal depletion
enclosed genes that are involved in development and pluripotency
(DPPA3, DPPA5, also involved in stemness, SNAI1, DDX20, MYC),
related with transcriptional processes (DDX20, EIF1, CLOCK), are
associated with germ cell specification and meiosis to spermatogen-
esis (CCNAI, DDX20, ZP1, ZP3, ZP4), to oocytes (GDF9, H1FOO,
CCNB1) and to both (YBX2), and also related with histones (H2AFZ).
Furthermore, we also found that the previously described gene
transcription activation markers include cell proliferation, pluripo-
tency and development-related genes (DPPA4, ITGA6, NASP,
POU5F1, TEAD4) cell differentiation markers (CDH1, TEAD4,
SLC1A3L, SLC2A14), transcriptional activation processes
(PAPBPC1, SNRPD2, EIF1AX, also related with stemness, NUDT21,
HMGB1, TEAD4), apoptosis (PDCD5, CDH1, PSMB3), histones
(H2AFY, NASP), and immune response (PSMA1). This list of genes
that were down- and up-regulated during the activation of the
zygote genome is a valuable tool which could be used in future
studies into the basic molecular mechanisms determining the
normal development of the pre-implantation embryo.
In conclusion, this is the first global genome study performed on
single human blastomeres at an early developmental stage. In
whole genomic comparison terms, and regarding a comparative
study conducted with more than 400 genes characteristic of ICM,
stemness and early differentiation to the trophectoderm, our
results indicate that blastomere fate in mRNA expression terms is
not determined at the 5–8 cell stage. EGA outcome has also been
assessed by genome-wide and comparisons made between
established gene pattern strategies at the single blastomere level.
Materials and Methods
Ethical statement
This study was approved by the institutional review board of the
Prince Felipe Research Centre. Permission for this Project was
granted by the Spanish Authority, Instituto de Salud Carlos III
(ISCIII) on December 13, 2006. Human embryos frozen at
different stages at the Instituto Valenciano de Infertilidad (IVI)
were donated for this work according to Spanish law 45/2003.
Progenitors were asked to sign a specific consent form for stem cell
derivation as indicated in Royal Decree 2132/2004.
Thaw and embryo culture
Day 3-stage human embryos were thawed using the Thaw Kit
(Vitrolife, Sweden) and incubated in pre-equilibrated CCM
medium (Vitrolife, Sweden) in a highly humidified incubator with
5% CO2 in air for at least 2 hours before the biopsy. All the
embryos used for the blastomere biopsy were grade I or II
according to a standard scoring system (embryos with blastomeres
of equal size with little or no cytoplasmic fragmentation) [70].
Blastomere Biopsy
Multiple blastomere biopsies were obtained from each embryo
following the single-cell biopsy procedure which is similar to that
used in the preimplantation genetic diagnosis (PGD). For
micromanipulation purposes, GPGD medium supplemented with
5% HSA was used (Vitrolife, Sweden). Briefly, blastomeres were
suctioned by making an approximately 50 mm diameter hole in the
zona pellucida with a specific 50 mm biopsy pipette (HumaGene
Inc, Scottsdale, USA), while the embryo was held with a holding
pipette. After pulling out the pipette entirely from the embryo, the
blastomere was expelled gently in the biopsy medium drop. This
procedure was repeated for each blastomere contained in all the
embryos. Separated blastomeres were washed 4 times in pre-
equilibrated CCM medium and placed separately in a lysis buffer
for the RNA extraction assay.
Inner Cell Mass (ICM) and Trophoectoderm (TE) isolation
Thawed day 3-stage embryos were cultured until day 6 in pre-
equilibrated CCM medium in a highly humidified incubator at
37uC and 5% CO2. Blastocysts were scored according to Gardner
and Schoolcraft [71]. All the blastocysts used to obtain inner cell
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mass (ICM) and trophectoderm (TE) separately were cavitated or
expanded with ICM grade A–B and TE grade A–B. ICM and TE
isolation was carried out using a micromanipulator with holding
micropipettes (Humagen, Charlottesville, VA) and an inverted
microscope. The blastocyst was placed in a drop of GPGD
medium (Vitrolife) supplemented with 5% Human Serum
Albumin (Vitrolife) in a micromanipulation plate (Beckton &
Dickinson) to be later held with the holding pipettes from both
sides in an attempt to localize ICM at the 9 o’clock position. ICM
was separated from TE by 20–30 infrared laser pulses (200 mW6
0.5 ms, Zilos-tkTM, Hamilton Thorne Biosciences) by applying
laser shots perpendicularly to the pipettes near ICM, and by
paying special attention not to damage it. When both parts were
separated, the zona pellucida was separated by careful pipetting,
and ICM and TE were placed separately in lysis buffer for
subsequent RNA extraction.
RNA amplification
Global mRNA amplification was performed following a
previously reported protocol with slight modifications [30]. The
biopsied single blastomeres collected in cell lysis buffer and
containing oligo (dT)-tagged primer V1 (dT)24, were incubated for
90 sec at 70uC, for cell lysis and RNA denaturalization. First-
strand cDNAs were synthesized by retro-transcription (RT) with
the SSIII (Invitrogen) for 20 min at 50uC and later inactivation at
70uC for 10 min. After RT, the remnant primer was degraded by
exonuclease I (Takara Bio, Japan) at 37uC for 30 min and a later
inactivation at 80uC for 25 min. cDNAs were then tailed with
poly(dA) by terminal deoxynucleotidyl transferase (TdT) (Invitro-
gen, CA, USA) at 37uC for 15 min and a later inactivation at 70uC
for 10 min. The cDNA products were divided into four tubes, and
the second strand of the poly(dA)-tailed cDNAs was synthesized
with another oligo(dT)-tagged primer,V3(dT)24 in an initial 1-cycle
PCR reaction consisting of 95uC for 3 min, 50uC for 2 min, and
72uC for 3 min, followed by a second 20-cycle PCR reaction
consisting of 95uC for 3 sec, 67uC for 1 min, and 72uC for 3 min
plus 6 additional seconds per cycle, and a final extension for
10 min at 72uC. PCR products were put together and purified
with the DNA Clean & ConcentratorTM Kit (Zymo Research, CA,
USA), eluted with 30 ml of double distilled water (Gibco BRL, CA,
USA) and quantified with a Nanodrop spectrophotometer
(NanoDrop Technologies, DW, USA). In this step, amplified
cDNA products were checked by qPCR with a ribosomal gene
(RPL19) to positively identify amplified cells. Then, purified
products were divided into 8 tubes, and 3 ml of each purified
cDNA were subjected to another PCR amplification reaction
containing the primers V3dT24 and T7V1 bearing the T7
promoter, consisting of 1 cycle of 95uC for 5 min and 30 sec,
64uC for 1 min and 72 uC for 18 sec, 10 cycles of 95uC for 30 sec,
67uC for 1 min, and 72uC for 5 min and 18 sec plus 6 additional
sec per cycle, and a final extension for 10 min at 72 uC. PCR
products were then purified with the DNA Clean & Concen-
tratorTM Kit (Zymo Research, CA, USA) and eluted with 30 ml of
double distilled water (Gibco BRL, Carlsbad, CA). Purified
products were electrophoresed and gel purified with the
ZymoCleanTM Gel DNA Recovery Kit (Zymo Research, CA,
USA) and eluted in 10 ml of Double Distilled Water (Gibco BRL,
CA, USA). Purified products were divided into 4 tubes, and 3 ml of
each purified cDNA were subjected to a final PCR cycle with
primers bearing the T7 promoter sequence (T7V1 and V3dT24
primers) consisting of 95uC for 5 min and 30 secs, 67uC for 1 min
and 72uC for 16 min. PCR products were put together and
purified with the DNA Clean & ConcentratorTM Kit (Zymo
Research, CA, USA). Purified cDNAs quantity and quality were
determined using the NanoDrop ND-1000 spectrophotometer
(Nanodrop Technologies, DW, USA) and the 2100 Bioanalyzer
(Agilent Technologies, CA, USA), respectively.
Microarrays Labelling and Hybridization
Supplied cDNAs were used to produce Cyanine 3-CTP-labeled
cRNA using the Quick Amp Labelling Kit, One-Color (Agilent
Technologies, CA, USA). The ‘One-Color Microarray-Based
Gene Expression Analysis’ protocol Version 5.7 (Agilent Tech-
nologies, CA, USA) was followed. The protocol was implemented
as follows: to 10 ml of cDNA, 4 ml of 56 First Stand Buffer and
6 ml of H2O were added. cDNA was labelled (2 hours or 16 hours)
in the IVT reaction with T7 RNA polymerase (Ambion, Austin,
USA) and the resulting cRNA was purified. Yield and Cy3 specific
activities were measured by spectrometry (Nanodrop Technolo-
gies, DW, USA) while cRNA length was evaluated by an mRNA
6000 Nano Bioanalyzer (Agilent Technologies, CA, USA) assay.
Hybridization was carried out following the ‘One-Color Micro-
array-Based Gene Expression Analysis’ protocol Version 5.7
(Agilent Technologies, CA, USA). Hybridization products were
incubated for 17 hours or 20 hours at specified temperature.
Those slides considered to have good and consistent hybridizations
were subjected to bioinformatic analyses. The data files have been
deposited in the NCBI Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO
series accession number GSE 22032. Results validation was
achieved by quantitative PCR.
Bioinformatic analyses
Samples were first filtered by comparison to the negative sample
microarray. Global intensity measurements of 6 microarrays were
no different to that of the water hybridized, thus these 6 samples
were considered to have no signal and were therefore excluded
from the analysis. The other 53 microarrays were left for the
analysis. The Agilent Processed Signals (Agilent Feature Extrac-
tion Software: http://www.chem.agilent.com/enus/products/
instruments/dnamicroarrays/featureextractionsoftware/pages/
default.aspx) were standardized across arrays using quantile
normalization [72]. A differential gene expression analysis was
carried out using the limma [73] package from Bioconductor
(http://www.bioconductor.org/). Multiple testing adjustment of the
p-values was done according to the methodology of Benjamini and
Hochberg [74]. The gene set analysis was carried out for the Gene
Ontology terms and for the KEGG Pathways using a logistic
regression model [75,76] GO annotations for the genes in the
microarrays were taken from the Ensembl 55 (http://www.
ensembl.org) release and KEGG Pathways from the KEGG web
page (http://www.genome.jp/kegg/). All analysis methods and
databases where used as implemented in Babelomics web tools [77]
(http://www.babelomics.org/).
Real-time PCR for microarrays validation
To verify the microarray data, real-time polymerase chain
reaction (qPCR) was used to check the gene expression profiles of
several target genes on the same samples used in the microarray
and in the cDNA from single biopsied and amplified blastomeres,
biopsied ICM and TE, amplified and non amplified. All the qPCR
reactions were performed in a LightcyclerH 2.0 (Roche Applied
Science, Germany) according to standard procedures. Next, 2 ml
of each sample were subjected to an initial denaturalization
program (95uC) for 10 min, followed by 45 amplification cycles
consisting in 10 sec at 95uC, an annealing step at 59uC for 6 sec
and a 10 sec extension step at 72uC where the SYBR GreenI
(Roche Applied Science, Germany) was visualized. Samples were
Human Blastomere Transcriptome
PLoS ONE | www.plosone.org 9 October 2010 | Volume 5 | Issue 10 | e13615
later subjected to a melting program to check for specific
amplification. All the qPCR experiments were normalized to the
housekeeping gene, RPS24. Each lot of experiments was
performed at least in triplicate and included a calibrator to check
experimental variation. The primers used for the validation are
listed in Supplementary Table S4.
Supporting Information
Table S1 Gene set analysis summary results for KEGG,
Biological process, Molecular function and cell components for
5-, 6- and 8-cell embryos comparing single blastomeres among
them and comparing each, 5- to 8-cell embryo blastomeres with
ICM and TE.
Found at: doi:10.1371/journal.pone.0013615.s001 (0.12 MB
XLS)
Table S2 Adjusted p values resulting for E5 (5-cell embryo single
blastomeres) E6 (6-cell embryo single blastomeres) and E8 (8-cell
embryo single blastomeres) comparison and among E5 E6 and E8
with ICM, for ICM and stemness signature, and with TE values
for TE signature. Adjusted p values ,0.05 were considered to be
significant. Normalized data for single blastomeres, and ICM or
TE, are also supplied.
Found at: doi:10.1371/journal.pone.0013615.s002 (0.43 MB
XLS)
Table S3 Significant adjusted p values (,0.05) showing novel
EGA genes as a result of E5 E6 and E8 comparison, and for
previously reported markers when E5, E6 and E8 were compared
to blastocysts (p values,0.05).
Found at: doi:10.1371/journal.pone.0013615.s003 (0.04 MB
XLS)
Table S4 List of primers used in this study for microarray data
validation by qPCR.
Found at: doi:10.1371/journal.pone.0013615.s004 (0.04 MB
DOC)
Figure S1 EGA signature. Heat map representation of the
significant differential expression between the 5–8 single blasto-
meres showing novel EGA genes (A) and compared with
blastocysts for previously reported genes (B). Red means an
overexpression in the blastocyst samples, and blue depicts an
overexpression in the single blastomere samples. The color code of
the expression level is indicated at the top of the figure.
Found at: doi:10.1371/journal.pone.0013615.s005 (0.65 MB TIF)
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